Fingerprint
Dive into the research topics of 'Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
Prajwal Boddu, Preetesh Jain, Gautam Borthakur, Srdan Verstovsek, Guillermo Garcia-Manero, Naval Daver, Tapan Kadia, Farhad Ravandi, Elias Jabbour, Jorge Cortes, Hagop Kantarjian
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations